2[3]Martha Mitch Funnell. Robert M. Anderson. The problem with compliance in diabetes. JAMA ,2000,284 ( 13 ): 1709.
3[6]Tebbi CK. Treatment compliance in childhood and adolescence. Cancer, 1993,71:3441.
4[7]Vaur L, Vaisse B, Genes N, et al. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large - scale trial. Am J Hypertens, 1999,12 (4 Pt 1 ): 374-380.
5[8]Andrejak M,Genes N,Vaur L,et al. Electronic pill boxes in the evaluation of antihypertensive treatment compliance:Comparison of once daily versus twice daily regimen. Am J Hypertens,2000,13 (2) :184-190.
6[9]Van Berge Henegouwen MT. Van Driel HF. Kasteleijn Nolst Trenite DG. A patient diary as a tool to improve medicine compliance. PharmWorldSci. 1999, 21 (1): 21 -24.
7[10]Spooren D,Van Heeringen C,Jannes C. Strategies to increase compliance with outpatient aftercare among patients referred to a psychiatric emergency department: a multicentre controlled intervention study.Psychol Med, 1998,28 (4) :949 - 956.
8National Comprehensive Cancer Network.结肠癌临床实践指南(中国版)[M/0L].[2007-10-07].http://www.nccn.org.
9Sabharwal A, Kerr D. Chemotherapy for colorectalcancer in the metastatic and adjuvant setting: past, present and future[J]. Expert Rev Anticancer, 2007,7:477 487.
10Tsavaris N, Kosmas C, Skopelitis H, et al. Sequential administration of 5 fluorouracil (5FU)/leucovorin(LV) followedby irinotecan(CPT. 11) at relap seversus CPT-11 followed by 5-FU/LV in advanced coloreetal carcinoma. A phase llI randomized study[J]. Chemotherapy, 2007,53: 282-291.
